AS

Ashok Sharma

Active Director Director DIN 08712986
DIN 08712986 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value •••• Premium profile

About Ashok Sharma

Data last updated:

Ashok Sharma is a Director at Balaji Pharmachem Private Limited (since 2020). The company operates in Pharma. Balaji Pharmachem Private Limited reported revenue of ₹3.34 Cr (FY 2024).

DIN 08712986
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 2020
Oldest Company Age 6 yrs
Largest company Balaji Pharmachem Private Limited · ₹3.34 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Balaji Pharmachem Private Limited U24304HR2020PTC085643
Director28 Feb 20202020₹3.34 Cr (FY 2024)Active

Board colleagues of Ashok Sharma

NameDINCompanyDesignation
Rakesh Kumar Nag08712987Balaji Pharmachem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Balaji Pharmachem Private Limited
Premium access

Shareholding and investment profile for Ashok Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Sharma

Ashok Sharma currently holds 1 directorship: Balaji Pharmachem Private Limited (Director, since 28 Feb 2020, revenue ₹3.34 Cr (FY 2024)).

Ashok Sharma was first appointed on 28 Feb 2020 as Director at Balaji Pharmachem Private Limited.

The current boards of Ashok Sharma's companies include Rakesh Kumar Nag (Balaji Pharmachem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available